{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:07:04Z","timestamp":1788941224948,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      BCR\u2010ABL1\u2010negative myeloproliferative neoplasms (MPNs) often exhibit overlapping clinical and morphological features, making accurate subcategorization challenging. The h\u2010MICL (CD371) antigen, selectively expressed on leukemic stem cells (LSCs) and absent on CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      cells in normal or regenerating marrow, represents a potential diagnostic and prognostic marker.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      This study aimed to evaluate the diagnostic utility of circulating CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells in subtyping BCR\u2010ABL1\u2010negative MPNs and to assess their correlation with the Dynamic International Prognostic Scoring System (DIPSS) score. Additionally, to identify a cut\u2010off value of CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells that can effectively differentiate PMF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifty\u2010four patients with BCR\u2010ABL1\u2010negative MPNs were prospectively enrolled at a tertiary care center in North India over 18\u2009months. Peripheral blood was analyzed via flow cytometry to quantify CD34\n                      <jats:sup>+<\/jats:sup>\n                      , CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      , CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      , and CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cell subsets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant increase in circulating CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells was observed in patients with overt MF (median 2.8%), prefibrotic MF (4.15%), and post\u2010PV\/ET MF (3%) compared to PV and ET (median 0%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A threshold of \u2265\u20090.9% CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells effectively identified MF cases with 88% sensitivity and 89% specificity. Moreover, a positive correlation was found between the percentage of CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells and DIPSS score (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009=\u20090.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036), with every 1.72% increase in this cell population corresponding to a 1\u2010point rise in DIPSS score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Circulating CD34\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>\u2212<\/jats:sup>\n                      h\u2010MICL\n                      <jats:sup>+<\/jats:sup>\n                      cells represent a promising biomarker; their quantification may aid in subclassification, particularly in distinguishing prefibrotic MF from ET, and may serve as a potential target for future therapeutic strategies. Further validation in larger cohorts is warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijlh.70128","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:20:28Z","timestamp":1777612828000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Flow Cytometric Enumeration of Circulating\n                    <scp>hMICL<\/scp>\n                    (\n                    <scp>CD371<\/scp>\n                    ) Positive Leukemic Stem Cells in Diagnosis and Prognostication of\n                    <scp>BCR<\/scp>\n                    ::\n                    <scp>ABL1<\/scp>\n                    \u2010Negative Myeloproliferative Neoplasms"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-5171","authenticated-orcid":false,"given":"Gurleen","family":"Oberoi","sequence":"first","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8282-7842","authenticated-orcid":false,"given":"Jasmita","family":"Dass","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Ganju","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-6829","authenticated-orcid":false,"given":"Ganesh","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Lata","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-1625","authenticated-orcid":false,"given":"Mukul","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Saxena","sequence":"additional","affiliation":[{"name":"Department of Hematology All India Institute of Medical Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.09.008"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03545.x"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018879"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPUAAC16LIWZMM"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13519"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14270"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15711"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12787"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.3"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538983"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25230"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-696005"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.22071"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.06.009"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-089003"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601462103"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0726-5"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3249"},{"issue":"10","key":"e_1_2_11_25_1","first-page":"1123","article-title":"Clinical Utility of the Absolute Number of Circulating CD34\u2010Positive Cells in Patients With Chronic Myeloproliferative Disorders","volume":"88","author":"Passamonti F.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3826"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3238"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20614"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.1724.1724"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.70128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:37:21Z","timestamp":1788939441000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.70128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/ijlh.70128"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.70128","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}